Oncology Institute (TOI) Asset Utilization Ratio (2021 - 2026)

Oncology Institute (TOI) has reported Asset Utilization Ratio for 6 consecutive years, with 3.28 the latest figure, recorded in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 3.28, up 36.93% year-over-year; the trailing twelve-month figure through Mar 2026 was 3.28 (up 36.93% YoY), and the FY2025 annual result was 2.98, up 44.67% from the prior year.
• Asset Utilization Ratio was 3.28 for Q1 2026 at Oncology Institute, up from 3.06 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 3.28 in Q1 2026 and troughed at 0.93 in Q4 2022.
• Average Asset Utilization Ratio over 5 years is 1.85, with a median of 1.66 recorded in 2024.
• Year-over-year, Asset Utilization Ratio declined 1.1% in 2022 and jumped 63.82% in 2023.
• Over 5 years, Asset Utilization Ratio stood at 0.93 in 2022, then surged by 63.82% to 1.52 in 2023, then jumped by 47.43% to 2.24 in 2024, then soared by 36.98% to 3.06 in 2025, then advanced by 7.06% to 3.28 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 3.28 in Q1 2026, 3.06 in Q4 2025, and 2.85 in Q3 2025.